CRABP1 provides high malignancy of transformed mesenchymal cells and contributes to the pathogenesis of mesenchymal and neuroendocrine tumors

Cell Cycle

Volumn 13, Issue 10, 2014, Pages 1530-1539

  Kainov, Yaroslav ^a   Favorskaya, Irina ^a   Delektorskaya, Vera ^a   Chemeris, Galina ^a   Komelkov, Andrei ^a   Zhuravskaya, Anna ^a   Trukhanova, Lyubov ^a   Zueva, Elina ^a,b   Tavitian, Bertrand ^a,c   Dyakova, Natalya ^a   Zborovskaya, Irina ^a   Tchevkina, Elena ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^b PSL RESEARCH UNIVERSITY   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

CRABP1; Metastasis; Pancreatic neuroendocrine tumors; Synovial sarcomas; Tumorigenicity

Indexed keywords

BIOLOGICAL MARKER; CELLULAR RETINOIC ACID BINDING PROTEIN 1; FATTY ACID BINDING PROTEIN; RETINOIC ACID; UNCLASSIFIED DRUG; RETINOIC ACID BINDING PROTEIN I, CELLULAR; RETINOIC ACID RECEPTOR;

ADULT; AGED; ANIMAL CELL; ARTICLE; CARCINOGENESIS; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MESENCHYME CELL; MESENCHYMOMA; MICROARRAY ANALYSIS; NONHUMAN; PANCREATIC NEUROENDOCRINE TUMOR; SPINDLE CELL; SYNOVIAL SARCOMA; SYRIAN HAMSTER; WESTERN BLOTTING; FIBROBLAST; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; METASTASIS; MIDDLE AGED; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PATHOLOGY; TRANSFORMED CELL LINE;

ADULT; AGED; CELL LINE, TRANSFORMED; FEMALE; FIBROBLASTS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; NEOPLASM METASTASIS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; RECEPTORS, RETINOIC ACID; SARCOMA, SYNOVIAL; TRETINOIN;

EID: 84900549027     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.28475     Document Type: Article

References (49)

1. Dong D, Ruuska SE, Levinthal DJ, Noy N. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J Biol Chem 1999; 274:23695-8; PMID:10446126; http://dx.doi.org/10.1074/ jbc.274.34.23695
2. Bushue N, Wan YJ. Retinoid pathway and cancer therapeutics. Adv Drug Deliv Rev 2010; 62:1285-98; PMID:20654663; http://dx.doi.org/10.1016/j.addr. 2010.07.003
3. Eichele G. Retinoic acid induces a pattern of digits in anterior half wing buds that lack the zone of polarizing activity. Development 1989; 107:863-7; PMID:2632237
4. Eichele G. Retinoids and vertebrate limb pattern formation. Trends Genet 1989; 5:246-51; PMID:2686112; http://dx.doi.org/10.1016/0168-9525(89)90096-6
5. Hoffmann S, Rockenstein A, Ramaswamy A, Celik I, Wunderlich A, Lingelbach S, Hofbauer LC, Zielke A. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells. Mol Cell Endocrinol 2007; 264:74-81; PMID:17101211; http://dx.doi.org/10.1016/j.mce.2006.10.009
6. Kim MS, Kim YK, Eun HC, Cho KH, Chung JH. All-trans retinoic acid antagonizes UV-induced VEGF production and angiogenesis via the inhibition of ERK activation in human skin keratinocytes. J Invest Dermatol 2006; 126:2697-706; PMID:16810296; http://dx.doi.org/10.1038/sj.jid.5700463
7. Luo P, Lin M, Lin M, Chen Y, Yang B, He Q. Function of retinoid acid receptor alpha and p21 in all-trans-retinoic acid-induced acute T-lymphoblastic leukemia apoptosis. Leuk Lymphoma 2009; 50:1183-9; PMID:19557639; http://dx.doi.org/10.1080/10428190902934936
8. Zhang Z, Joh K, Yatsuki H, Zhao W, Soejima H, Higashimoto K, Noguchi M, Yokoyama M, Iwasaka T, Mukai T. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells. Cancer Lett 2007; 247:318-27; PMID:16806674; http://dx.doi.org/10.1016/j.canlet.2006.05.013
9. Osanai M, Sawada N, Lee GH. Oncogenic and cell survival properties of the retinoic acid metabolizing enzyme, CYP26A1. Oncogene 2010; 29:1135-44; PMID:19935721; http://dx.doi.org/10.1038/onc.2009.414
10. Kim H, Lapointe J, Kaygusuz G, Ong DE, Li C, van de Rijn M, Brooks JD, Pollack JR. The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. Cancer Res 2005; 65:8118-24; PMID:16166285; http://dx.doi.org/10.1158/0008-5472.CAN-04-4562
11. Tang XH, Vivero M, Gudas LJ. Overexpression of CRABPI in suprabasal keratinocytes enhances the proliferation of epidermal basal keratinocytes in mouse skin topically treated with all-trans retinoic acid. Exp Cell Res 2008; 314:38-51; PMID:17727842; http://dx.doi.org/10.1016/j.yexcr.2007.07.016
12. Won JY, Nam EC, Yoo SJ, Kwon HJ, Um SJ, Han HS, Kim SH, Byun Y, Kim SY. The effect of cellular retinoic acid binding protein-I expression on the CYP26-mediated catabolism of all-trans retinoic acid and cell proliferation in head and neck squamous cell carcinoma. Metabolism 2004; 53:1007-12; PMID:15281009; http://dx.doi.org/10.1016/j.metabol.2003.12.015
13. Boylan JF, Gudas LJ. Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells. J Cell Biol 1991; 112:965-79; PMID:1847931; http://dx.doi.org/10.1083/jcb.112.5.965
14. Venepally P, Reddy LG, Sani BP. Analysis of the effects of CRABP I expression on the RA-induced transcription mediated by retinoid receptors. Biochemistry 1996; 35:9974-82; PMID:8756459; http://dx.doi.org/10.1021/bi9603276
15. Ahlquist T, Lind GE, Costa VL, Meling GI, Vatn M, Hoff GS, Rognum TO, Skotheim RI, Thiis-Evensen E, Lothe RA. Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. Mol Cancer 2008; 7:94; PMID:19117505; http://dx.doi.org/10.1186/1476-4598-7-94
16. Lee HS, Kim BH, Cho NY, Yoo EJ, Choi M, Shin SH, Jang JJ, Suh KS, Kim YS, Kang GH. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma. Clin Cancer Res 2009; 15:812-20; PMID:19188151; http://dx.doi.org/10.1158/1078- 0432.CCR-08-0266
17. Hawthorn L, Stein L, Varma R, Wiseman S, Loree T, Tan D. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma. Head Neck 2004; 26:1069-83; PMID:15515157; http://dx.doi.org/10.1002/hed.20099
18. Pfoertner S, Goelden U, Hansen W, Toepfer T, Geffers R, Ukena SN, von Knobloch R, Hofmann R, Buer J, Schrader AJ. Cellular retinoic acid binding protein I: expression and functional influence in renal cell carcinoma. Tumour Biol 2005; 26:313-23; PMID:16254461; http://dx.doi.org/10.1159/000089262
19. Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, Shimada Y, Aiko S, Yoshizumi Y, Iwai T, Kawano T, et al. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma. Oncogene 2007; 26:6456-68; PMID:17438526; http://dx.doi.org/10.1038/sj.onc. 1210459
20. Miyake T, Ueda Y, Matsuzaki S, Miyatake T, Yoshino K, Fujita M, Nomura T, Enomoto T, Kimura T. CRABP1-reduced expression is associated with poorer prognosis in serous and clear cell ovarian adenocarcinoma. J Cancer Res Clin Oncol 2011; 137:715-22; PMID:20571827; http://dx.doi.org/10.1007/s00432-010- 0930-8
21. Banz C, Ungethuem U, Kuban RJ, Diedrich K, Lengyel E, Hornung D. The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer. Fertil Steril 2010; 94:1212-7; PMID:19643405; http://dx.doi.org/10.1016/ j.fertnstert.2009.06.039
22. Siddiqui NA, Thomas EJ, Dunlop W, Redfern CP. Retinoic acid receptors and retinoid binding proteins in endometrial adenocarcinoma: differential expression of cellular retinoid binding proteins in endometrioid tumours. Int J Cancer 1995; 64:253-63; PMID:7657389; http://dx.doi.org/10.1002/ijc.2910640408
23. Illán Rubio L, Tavitian B, Zueva E. Similar expression profiles of a core of genes and proteins in cells that have acquired a metastatic phenotype, genetically or by in vivo evolution. Clin Exp Metastasis 2010; 27:409-18; PMID:19904617; http://dx.doi.org/10.1007/s10585-009-9297-0
24. Tchevkina E, Agapova L, Dyakova N, Martinjuk A, Komelkov A, Tatosyan A. The small G-protein RalA stimulates metastasis of transformed cells. Oncogene 2005; 24:329-35; PMID:15467745; http://dx.doi.org/10.1038/sj.onc.1208094
25. Deichman GI, Kashleva HA, Kluchareva TE, Matveeva VA. Clustering of discrete cell properties essential for tumorigenicity and metastasis. II. Studies of Syrian hamster embryo fibroblasts transformed by Rous sarcoma virus. Int J Cancer 1989; 44:908-10; PMID:2555309; http://dx.doi.org/10.1002/ijc. 2910440527
26. Wei LN, Chang L, Hu X. Studies of the type I cellular retinoic acid-binding protein mutants and their biological activities. Mol Cell Biochem 1999; 200:69-76; PMID:10569185; http://dx.doi.org/10.1023/A:1006906415388
27. de Thé H, Vivanco-Ruiz MM, Tiollais P, Stunnenberg H, Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 1990; 343:177-80; PMID:2153268; http://dx.doi.org/10. 1038/343177a0
28. Perez-Castro AV, Tran VT, Nguyen-Huu MC. Defective lens fiber differentiation and pancreatic tumorigenesis caused by ectopic expression of the cellular retinoic acid-binding protein I. Development 1993; 119:363-75; PMID:8287793
29. Allander SV, Illei PB, Chen Y, Antonescu CR, Bittner M, Ladanyi M, Meltzer PS. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol 2002; 161:1587-95; PMID:12414507; http://dx.doi.org/10.1016/S0002- 9440(10)64437-9
30. Nagayama S, Katagiri T, Tsunoda T, Hosaka T, Nakashima Y, Araki N, Kusuzaki K, Nakayama T, Tsuboyama T, Nakamura T, et al. Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray. Cancer Res 2002; 62:5859-66; PMID:12384549
31. Ruff SJ, Ong DE. Cellular retinoic acid binding protein is associated with mitochondria. FEBS Lett 2000; 487:282-6; PMID:11150525; http://dx.doi.org/10.1016/S0014-5793(00)02366-8
32. Levadoux-Martin M, Li Y, Blackburn A, Chabanon H, Hesketh JE. Perinuclear localisation of cellular retinoic acid binding protein I mRNA. Biochem Biophys Res Commun 2006; 340:326-31; PMID:16376305; http://dx.doi.org/10.1016/j.bbrc. 2005.12.006
33. Daub H, Olsen JV, Bairlein M, Gnad F, Oppermann FS, Körner R, Greff Z, Kéri G, Stemmann O, Mann M. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell 2008; 31:438-48; PMID:18691976; http://dx.doi.org/10.1016/j.molcel.2008.07.007
34. Ho MM, Ng AV, Lam S, Hung JY. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007; 67:4827-33; PMID:17510412; http://dx.doi.org/10.1158/0008-5472.CAN-06-3557
35. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445:111-5; PMID:17122771; http://dx.doi.org/10.1038/nature05384
36. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100:3983-8; PMID:12629218; http://dx.doi.org/10.1073/pnas. 0530291100
37. Will B, Vogler TO, Bartholdy B, Garrett-Bakelman F, Mayer J, Barreyro L, Pandolfi A, Todorova TI, Okoye-Okafor UC, Stanley RF, et al. Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitment. Nat Immunol 2013; 14:437-45; PMID:23563689; http://dx.doi.org/10.1038/ni.2572
38. Mao L, Yang C, Wang J, Li W, Wen R, Chen J, Zheng J. SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion. J Transl Med 2013; 11:111; PMID:23642278; http://dx.doi.org/10.1186/1479-5876-11-111
39. Zhang J, Zhang B, Zhang X, Sun Y, Wei X, McNutt MA, Lu S, Liu Y, Zhang D, Wang M, et al. SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo. PLoS One 2013; 8:e47902; PMID:23326301; http://dx.doi.org/10.1371/journal.pone.0047902
40. Asanoma K, Kubota K, Chakraborty D, Renaud SJ, Wake N, Fukushima K, Soares MJ, Rumi MA. SATB homeobox proteins regulate trophoblast stem cell renewal and differentiation. J Biol Chem 2012; 287:2257-68; PMID:22123820; http://dx.doi.org/10.1074/jbc.M111.287128
41. Klein D, Benchellal M, Kleff V, Jakob HG, Ergün S. Hox genes are involved in vascular wall-resident multipotent stem cell differentiation into smooth muscle cells. Sci Rep 2013; 3:2178; PMID:24145756; http://dx.doi.org/10. 1038/srep02178
42. Narayanan G, Poonepalli A, Chen J, Sankaran S, Hariharan S, Yu YH, Robson P, Yang H, Ahmed S. Single-cell mRNA profiling identifies progenitor subclasses in neurospheres. Stem Cells Dev 2012; 21:3351-62; PMID:22834539; http://dx.doi.org/10.1089/scd.2012.0232
43. Hsu YC, Liao WC, Kao CY, Chiu IM. Regulation of FGF1 gene promoter through transcription factor RFX1. J Biol Chem 2010; 285:13885-95; PMID:20189986; http://dx.doi.org/10.1074/jbc.M109.081463
44. Hoffman B, Amanullah A, Shafarenko M, Liebermann DA. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene 2002; 21:3414-21; PMID:12032779; http://dx.doi.org/10.1038/sj.onc.1205400
45. Klimstra DS, Yang Z. Pathology, classification, and grading of neuroendocrine tumors arising in the digestive system. In: Basow D, ed. UpToDate: Waltham, MA, 2013.
46. Khromova N, Kopnin P, Rybko V, Kopnin BP. Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms. Oncogene 2012; 31:1389-97; PMID:21804602; http://dx.doi.org/10.1038/onc.2011.330
47. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 2009; 10:48; PMID:19192299; http://dx.doi.org/10.1186/1471-2105- 10-48
48. Eden E, Lipson D, Yogev S, Yakhini Z. Discovering motifs in ranked lists of DNA sequences. PLoS Comput Biol 2007; 3:e39; PMID:17381235; http://dx.doi.org/10.1371/journal.pcbi.0030039
49. Barrett T, Edgar R. Gene expression omnibus: microarray data storage, submission, retrieval, and analysis. Methods Enzymol 2006; 411:352-69; PMID:16939800; http://dx.doi.org/10.1016/S0076-6879(06)11019-8